Results of laparoscopic splenectomy for treatment of malignant conditions

Abstract

LS is a safe procedure in patients with malignant disease requiring splenectomy in spite of the longer operative time and the higher conversion rate.

The Feasibility and Safety of Laparoscopic Splenectomy for Massive Splenomegaly: A Comparative Study

“…However, most of our patients with splenomegaly underwent laparoscopic splenectomy successfully. Only one conversion was required in group 1 due to the excessive bleeding [22]. Although the greater mean splenic volume of patients in group 1 may have longer operation time, higher complication rates, and longer postoperative hospital stay, there were no significant differences in terms of intraoperative blood loss, blood transfusion, or conversion rate.…”

Long-term outcome after laparoscopic splenectomy related to hematologic diagnosis

“…The main reason for conversion in our malignant group was spleen size, due to the impossibility of handling [23,24]. New devices for hand-assisted laparoscopic surgery (HALS) have become available, and this technique can be especially useful in cases of LS for splenomegaly or malignancy [22,26].…”

Predictive factors for successful laparoscopic splenectomy in immune thrombocytopenic purpura

“…Since the first laparoscopic splenectomy (LS) was reported in 1992 [6], there has been renewed interest in managing hematologic disorders with minimally invasive surgical techniques [19,30]. Laparoscopic splenectomy is less painful, requires a shorter hospital stay, allows a faster return to full activity, and provides superior cosmesis compared to open techniques [32,37].…”